Author： Moyle G.J.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.4, 1999-04, pp. : 473-486
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efavirenz-containing regimens superior in HIV-1 infection?
Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. :
Access to resources
Recommend
Cognitive impairment associated with HIV-1 infection seems to be improved by HAART
Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. :
Efavirenz- and nevirapine-based HAART equally effective in HIV infections
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
Efavirenz: A Pharmacoeconomic Review of its Use in HIV Infection
By Plosker G.L. Perry C.M. Goa K.L.
PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. :